Cell Line License Agreement

Dec 5th, 2020 | By | Category: Uncategorized

ATCC recognizes the potential benefits of ATCC products in commercial applications. To meet these needs, ATCC has implemented an out-of-service licensing program that allows establishments to use ATCC products for commercial purposes as part of a non-exclusive licensing agreement. While ATCC views the Material Transfer Agreement (MTA) as an essential component of the distribution of its biological materials, the ATCC Commercial Use Licensing Program helps protect ATCC`s ability to provide research materials for the benefit of the scientific community. Notice of proposed third-party products – In the case of an exclusive license granted in all or in many areas, the licensee may first focus on a limited number of products or uses for the technology granted. In order to support Harvard`s mission to promote the common good by commercializing Harvard`s technology as widely as possible, Harvard may include provisions similar to those in the link below, to encourage a taker to develop third-party products or to sublicate the Harvard patent licensee`s rights to a third party to enable the development and commercialization of additional products. A license for patent rights held by Harvard is subject to conditions similar to those provided in the form agreements in the links below. Some concepts can be changed to take into account the clear aspects of each situation. In particular, financial conditions are established on the basis of the technology granted, the licensee`s business model and the market standards in the sector in which the taker operates. According to the MTA ATCC, “commercial exploitation is the sale, license, leasing, export, transfer or distribution of organic materials to a person or organization that is not a party to this MTA, for financial or commercial purposes, and/or the use of biological material: (a) to provide a service to a person or organization that is not a party to that MTA, for financial gain; (b) to manufacture or manufacture products for general sale or manufacture of products for general sale; or (c) with respect to performance testing services, including, but not only for the provision of the service, to determine laboratory performance by comparing and cancelling calibrations or tests performed on the same object or material or on similar materials under the specified conditions.” This type of agreement allows Harvard researchers who are creating a new licensed business without difficulty to copyrighted non-patentable software that they have developed as part of the faculty`s research efforts.

In cases where there are patentable topics such as unique algorithms, please read the “Exclusive Basic License” agreement model published above. After the agreement is signed, you will receive 2 vials of frozen cells, a cell culture protocol and a test protocol to perform inhibition tests and you will have access to technical assistance from SOLVO staff. Global Access Note – The development of Technologies from Harvard Patents can lead to licensed products that could bring significant public health benefits in developing countries. By participating in Universities Allied for Essential Medicines, Harvard is committed to promoting affordable access to these products in developing countries.

Comments are closed.